seridopidine (ACR343)
/ Saniona
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 28, 2012
NeuroSearch announces the company's annual Report 2011
(Neurosearch)
- Together with Huntexil, seridopidine & ordopidine constitute a range of patent families which are important to NeuroSearch; Seridopidine has been evaluated in P1 clinical studies with satisfactory results; Ordopidine has finalised the active part of a P1b study & data are currently being analysed; In order to focus on the development of Huntexil, NeuroSearch has decided not to initiate P2 studies for seridopidine and ordopidine at this time
Product update • Parkinson's Disease • Schizophrenia
1 to 1
Of
1
Go to page
1